ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly collaboration and other revenue ($M) ($M)
Form 10-Q / 10-K Disaggregated Revenue Note
Latest, Q2 2026
1,571
Period ended Jun 30, 2026
Change on a year earlier
+88.8%
832 in Q2 2025
History
37 quarters
Since Q2 2017
Sources
32
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Eli Lilly Collaboration and other revenue ($M) ($M), quarterly Q2 2017–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/rev_collaboration
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.